SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today the publication of early post-approval clinical experience from the use of the QUELIMMUNE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results